Gharibo Christopher, Drewes Asbjørn M, Breve Frank, Rekatsina Martina, Narvaez Tamayo Marco Antonio, Varrassi Giustino, Paladini Antonella
Pain Management, NYU Langone Health, New York City, USA.
Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, DNK.
Cureus. 2023 Sep 2;15(9):e44583. doi: 10.7759/cureus.44583. eCollection 2023 Sep.
Pain regimens, particularly for chronic cancer and noncancer pain, must balance the important analgesic benefits against potential risks. Many effective and frequently used pain control regimens are associated with iatrogenic adverse events. Interventional procedures can be associated with nerve injuries, vascular injuries, trauma to the spinal cord, and epidural abscesses. Although rare, these adverse events are potentially catastrophic. Pharmacologic remedies for pain must also consider potential side effects that can occur even at therapeutic doses of over-the-counter remedies such as paracetamol (acetaminophen) or nonsteroidal anti-inflammatory drugs. Opioids are effective pain relievers but are associated with many side effects, some of which can be treatment limiting. A prevalent and distressing side effect of opioid therapy is constipation. Opioid-induced constipation is caused by binding to opioid receptors in the gastrointestinal system, making conventional laxatives ineffective. Peripherally acting mu-opioid receptor antagonists are a new drug class that offers the benefits of preserving opioid analgesia without side effects in the gastrointestinal system. An important safety concern, particularly among geriatric patients is the increasingly prevalent condition of polypharmacy. Many senior patients take five or more medications, including some that may be contraindicated in geriatric patients, duplicative of other drugs, have potential pharmacokinetic drug-drug interactions, or may not be the optimal choice for the patient's age and condition. Careful assessment of medications in the elderly, including possibly deprescribing with tapering of certain drugs, may be warranted but should be done systematically and under clinical supervision.
疼痛治疗方案,尤其是针对慢性癌症疼痛和非癌症疼痛的方案,必须在重要的镇痛益处与潜在风险之间取得平衡。许多有效且常用的疼痛控制方案都与医源性不良事件相关。介入性操作可能会导致神经损伤、血管损伤、脊髓创伤和硬膜外脓肿。尽管这些不良事件很少见,但却具有潜在的灾难性。疼痛的药物治疗还必须考虑即使在使用对乙酰氨基酚(扑热息痛)或非甾体抗炎药等非处方治疗药物的治疗剂量时也可能出现的潜在副作用。阿片类药物是有效的止痛剂,但会产生许多副作用,其中一些副作用可能会限制治疗。阿片类药物治疗中一种普遍且令人苦恼的副作用是便秘。阿片类药物引起的便秘是由于与胃肠道系统中的阿片受体结合所致,使得传统泻药无效。外周作用的μ-阿片受体拮抗剂是一类新药,它具有在不产生胃肠道系统副作用的情况下保留阿片类药物镇痛效果的优点。一个重要的安全问题,尤其是在老年患者中,是日益普遍的多重用药情况。许多老年患者服用五种或更多药物,其中一些药物可能在老年患者中是禁忌的,与其他药物重复,存在潜在的药代动力学药物相互作用,或者可能不是适合患者年龄和病情的最佳选择。对老年人的药物进行仔细评估,包括可能逐渐减少某些药物的用量,可能是有必要的,但应该在临床监督下系统地进行。